Lexeo Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 6.11 M | $40.49 M | 65.71% | 10.01% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 4.42 M | $29.38 M | 0.00% | 7.26% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 3.91 M | $25.99 M | -2.38% | 6.42% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 3.87 M | $25.70 M | 7.83% | 6.35% |
| CITADEL ADVISORS LLC | 11/14/2025 | 3.72 M | $24.69 M | 3.08% | 6.10% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 3.25 M | $21.58 M | 0.68% | 5.33% |
| WOODLINE PARTNERS LP | 11/14/2025 | 2.57 M | $17.08 M | 0.00% | 4.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 2.31 M | $15.36 M | -18.43% | 3.79% |
| VANGUARD GROUP INC | 11/07/2025 | 2.23 M | $14.78 M | 11.16% | 3.65% |
| BLACKROCK, INC. | 11/12/2025 | 2.17 M | $14.42 M | 18.77% | 3.56% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.94 M | $12.89 M | 199.72% | 3.18% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.53 M | $10.17 M | 955.73% | 2.51% |
| BLACKSTONE INC. | 11/14/2025 | 1.12 M | $7.47 M | 0.00% | 1.84% |
| D1 CAPITAL PARTNERS L.P. | 11/14/2025 | 978.65 K | $6.50 M | 0.00% | 1.60% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 922.66 K | $6.13 M | 100.00% | 1.51% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 912.53 K | $6.06 M | 1,840.61% | 1.50% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 778.61 K | $5.17 M | 100.00% | 1.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 721.88 K | $4.79 M | 24.88% | 1.18% |
| SIREN, L.L.C. | 11/13/2025 | 603.44 K | $4.01 M | 0.00% | 0.99% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 567.60 K | $3.77 M | 3.19% | 0.93% |
| STATE STREET CORP | 11/14/2025 | 544.85 K | $3.62 M | 6.20% | 0.89% |
| VERITION FUND MANAGEMENT LLC | 11/14/2025 | 414.86 K | $2.75 M | 0.00% | 0.68% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 358.08 K | $2.38 M | -5.29% | 0.59% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 347.92 K | $2.31 M | 84.44% | 0.57% |
| UBS GROUP AG | 11/13/2025 | 249.91 K | $1.66 M | -8.09% | 0.41% |
| NORTHERN TRUST CORP | 11/14/2025 | 236.45 K | $1.57 M | 17.76% | 0.39% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 192.36 K | $1.28 M | 7.85% | 0.32% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 180.74 K | $1.20 M | 10.77% | 0.30% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 166.54 K | $1.11 M | 100.00% | 0.27% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 149.30 K | $991.35 K | 40.58% | 0.24% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 142.40 K | $945.55 K | 291.56% | 0.23% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 139.84 K | $928.50 K | 0.00% | 0.23% |
| JANE STREET GROUP, LLC | 11/14/2025 | 129.47 K | $859.69 K | 100.00% | 0.21% |
| BARCLAYS PLC | 11/12/2025 | 111.58 K | $740.89 K | -3.93% | 0.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 105.76 K | $702.25 K | 64.68% | 0.17% |
| MORGAN STANLEY | 11/14/2025 | 98.06 K | $651.10 K | 15.66% | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 84.76 K | $562.83 K | 22.42% | 0.14% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 71.68 K | $475.94 K | 10.02% | 0.12% |
| PALUMBO WEALTH MANAGEMENT LLC | 11/10/2025 | 61.28 K | $406.87 K | 8.83% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 48.40 K | $321.38 K | -9.36% | 0.08% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 43.27 K | $287.00 K | 100.00% | 0.07% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 36.15 K | $240.06 K | 100.00% | 0.06% |
| SAVANT CAPITAL, LLC | 11/05/2025 | 34.91 K | $231.83 K | 17.69% | 0.06% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 34.30 K | $227.73 K | -1.28% | 0.06% |
| PALE FIRE CAPITAL SE | 11/13/2025 | 33.65 K | $223.44 K | 21.70% | 0.06% |
| IEQ CAPITAL, LLC | 11/14/2025 | 33.58 K | $222.98 K | 183.36% | 0.06% |
| NUVEEN, LLC | 11/12/2025 | 33.10 K | $219.80 K | 0.00% | 0.05% |
| RHUMBLINE ADVISERS | 11/06/2025 | 31.76 K | $210.91 K | -0.71% | 0.05% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 30.73 K | $204.03 K | -36.56% | 0.05% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 29.37 K | $195.02 K | 0.00% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lexeo Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 121 institutional investors and hedge funds held shares of Lexeo Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 6.11 M
Frazier Life Sciences Management, L.P.: 4.42 M
BALYASNY ASSET MANAGEMENT L.P.: 3.91 M
Affinity Asset Advisors, LLC: 3.87 M
CITADEL ADVISORS LLC: 3.72 M
Vestal Point Capital, LP: 3.25 M
80.94% of Lexeo Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 50.22 M shares in the last 24 months. This purchase volume represents approximately $456.49 M in transactions.